| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2010 | EP2205585A1 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 07/14/2010 | EP2205584A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 07/14/2010 | EP2205583A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 07/14/2010 | EP2205579A1 Compounds of 2,3-dihydro-benzofuran |
| 07/14/2010 | EP2205576A1 Benzothiazoles as ghrelin receptor modulators |
| 07/14/2010 | EP2205575A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 07/14/2010 | EP2205573A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 07/14/2010 | EP2205570A1 2-s-benzyl substituted pyrimidines as crth2 antagonists |
| 07/14/2010 | EP2205569A1 Alkylthio pyrimidines as crth2 antagonists |
| 07/14/2010 | EP2205568A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 07/14/2010 | EP2205567A1 Gamma secretase modulators |
| 07/14/2010 | EP2205565A1 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 07/14/2010 | EP2205564A1 Novel kinase inhibitors |
| 07/14/2010 | EP2205563A2 Novel histone deacetylase inhibitors |
| 07/14/2010 | EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 07/14/2010 | EP2205561A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/14/2010 | EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors |
| 07/14/2010 | EP2205559A1 Renin inhibitors |
| 07/14/2010 | EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 07/14/2010 | EP2205548A1 Substituted biphenyl gpr40 modulators |
| 07/14/2010 | EP2205317A1 Pyridine derivatives for the treatment of amyloid-related diseases |
| 07/14/2010 | EP2205278A1 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 07/14/2010 | EP2205268A1 Interferon alpha sequential regimen for treating cancers |
| 07/14/2010 | EP2205264A1 Molecular delivery vesicle |
| 07/14/2010 | EP2205250A1 ß-GLUCAN TREATMENT OF UPPER RESPIRATORY TRACT INFECTION SYMPTOMS AND PSYCHOLOGICAL WELL-BEING |
| 07/14/2010 | EP2205249A2 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| 07/14/2010 | EP2205248A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 07/14/2010 | EP2205245A1 Therapeutic use of diaminophenothiazines |
| 07/14/2010 | EP2205244A1 Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea to treat proliferative disease |
| 07/14/2010 | EP2205243A2 Mast cell stabilizers in the treatment of obesity |
| 07/14/2010 | EP2205242A2 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 07/14/2010 | EP2205241A1 Polo-like kinase inhibitors |
| 07/14/2010 | EP2205240A1 Endocannabinoids for enhancing growth and development in infants |
| 07/14/2010 | EP2205239A2 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 07/14/2010 | EP2205238A2 Combination therapy related to serotonin dual action compounds |
| 07/14/2010 | EP2205237A1 Methods for protecting the skin from radiation insults |
| 07/14/2010 | EP2205236A2 Novel agents for treatment of ailments and dysfunctions |
| 07/14/2010 | EP2205235A2 Formulation to improve gastrointestinal function |
| 07/14/2010 | EP2205234A2 Methods and compounds for treating retinol-related diseases |
| 07/14/2010 | EP2205232A2 Galenical formulations of aliskiren |
| 07/14/2010 | EP2205230A1 Anti-microbial composition |
| 07/14/2010 | EP2205229A1 Compounds and methods for pharmaceutical use |
| 07/14/2010 | EP2205222A1 Lyophilized pharmaceutical compositions |
| 07/14/2010 | EP2205219A1 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 07/14/2010 | EP2205218A1 Pharmaceutical composition containing esomeprazole |
| 07/14/2010 | EP2205215A2 Docetaxel injectable composition, being absolutely free of ethanol |
| 07/14/2010 | EP2205214A2 Oral fast disintegrating tablets |
| 07/14/2010 | EP2205213A2 Orodispersible tablets |
| 07/14/2010 | EP2205204A1 Therapy option for recoloration of hair via bisphosphonates by physiological repigmentation with age-related and/or premature "grayed" patients |
| 07/14/2010 | EP2205194A1 Alloplastic injectable dermal filler and methods of use thereof |
| 07/14/2010 | EP2205079A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 07/14/2010 | EP2205078A1 Production of monatin stereoisomers |
| 07/14/2010 | EP2205077A1 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| 07/14/2010 | EP2205076A1 Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr ýerbb1¨and her-2 ýerbb2¨ |
| 07/14/2010 | EP2205075A1 Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonists |
| 07/14/2010 | EP2205074A2 Moenomycin analogs, methods of synthesis, and uses thereof |
| 07/14/2010 | EP2205073A1 Azacytidine analogues and uses thereof |
| 07/14/2010 | EP2205072A1 Methods for treating a variety of diseases and conditions, and compounds useful therefor |
| 07/14/2010 | EP2205071A1 Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and trkb agonists |
| 07/14/2010 | EP2205070A1 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors |
| 07/14/2010 | EP2205069A1 Combretum laurifolium mart. extract and methods of extracting and using such extract |
| 07/14/2010 | EP2024355B1 Alkene piperidine derivatives as antiviral agents |
| 07/14/2010 | EP2021333B1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 07/14/2010 | EP1991223B1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 07/14/2010 | EP1966218B1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/14/2010 | EP1951659B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 07/14/2010 | EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 07/14/2010 | EP1853602B1 Chemical compounds |
| 07/14/2010 | EP1824830B1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 07/14/2010 | EP1784188B1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/14/2010 | EP1778236B1 Modified pyrimidine glucocorticoid receptor modulators |
| 07/14/2010 | EP1751161B1 Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 07/14/2010 | EP1723138B1 Substituted benzimidazoles and their use for inducing apoptosis |
| 07/14/2010 | EP1699778B1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 07/14/2010 | EP1696900B1 Use of treprostinil to treat ischemic lesions |
| 07/14/2010 | EP1689721B1 Aminopyrazole derivatives as gsk-3 inhibitors |
| 07/14/2010 | EP1687312B1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 07/14/2010 | EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 07/14/2010 | EP1636224B1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 07/14/2010 | EP1585524B1 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 07/14/2010 | EP1575959B1 Compositions useful as inhibitors of protein kinases |
| 07/14/2010 | EP1551849B1 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/14/2010 | EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 07/14/2010 | EP1514116B9 Oxaliplatin anti-resistance method |
| 07/14/2010 | EP1513859B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 07/14/2010 | EP1490030B2 Nanoparticulate compositions of angiogenesis inhibitors |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/14/2010 | EP1203587B1 A medicament and method for the production thereof |
| 07/14/2010 | EP1200100B1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 07/14/2010 | CN201524271U Lovastatin-nicotinic acid double-release capsule |
| 07/14/2010 | CN201524270U Combined capsule loaded with glycyrrhizin solid preparation and glycine solid preparation |
| 07/14/2010 | CN201524269U Combined capsule loaded with replaglinide solid preparation and metformin solid preparation |
| 07/14/2010 | CN201524268U Extended release pills in micro-capsules |
| 07/14/2010 | CN201523733U Anti-plague spice-adorning product |
| 07/14/2010 | CN1980933B Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 07/14/2010 | CN1955179B [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents |
| 07/14/2010 | CN1935176B Method for preparing red flower extract containing total red flower uranidin |
| 07/14/2010 | CN1882508B Process for preparing water soluble diterpenes and their applications |
| 07/14/2010 | CN1859916B Drugs, foods and drinks for ameliorating hyperglycemia |